Melanie Korsen
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Altered network recruitment in multiple sclerosis patients during resting state.
Journal: Multiple sclerosis and related disorders
Published: August 22, 2025
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.
Journal: Journal of neuroinflammation
Published: September 15, 2024
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: December 02, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.
Journal: Frontiers in immunology
Published: September 05, 2022
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 27, 2022
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.
Journal: Neurological research and practice
Published: May 27, 2022
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched study.
Journal: Therapeutic advances in neurological disorders
Published: April 30, 2022
Sirolimus leads to rapid and sustained clinical improvement of motor deficits in a patient with inclusion body myositis.
Journal: European journal of neurology
Published: November 27, 2021
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 09, 2021
Last Updated: 09/26/2026